| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,061 |
1,008 |
$460K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,495 |
1,523 |
$460K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,292 |
2,026 |
$371K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,436 |
5,843 |
$303K |
| 80053 |
Comprehensive metabolic panel |
10,244 |
7,905 |
$180K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,586 |
3,034 |
$157K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,467 |
1,292 |
$151K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,696 |
8,586 |
$114K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
642 |
559 |
$90K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
435 |
386 |
$85K |
| 87428 |
|
927 |
818 |
$66K |
| 82553 |
|
1,936 |
1,672 |
$64K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,957 |
1,701 |
$60K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,439 |
1,166 |
$60K |
| 71045 |
Radiologic examination, chest; single view |
2,863 |
2,489 |
$55K |
| 84484 |
|
2,486 |
2,145 |
$52K |
| 71046 |
Radiologic examination, chest; 2 views |
1,900 |
1,605 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,536 |
2,777 |
$44K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,819 |
3,341 |
$42K |
| 82550 |
|
2,324 |
1,895 |
$42K |
| 87400 |
|
6,262 |
2,868 |
$41K |
| 83880 |
|
568 |
493 |
$35K |
| 80305 |
|
1,463 |
1,216 |
$34K |
| 83605 |
|
1,218 |
1,059 |
$30K |
| 81001 |
|
5,195 |
4,199 |
$27K |
| 36415 |
Collection of venous blood by venipuncture |
2,916 |
2,239 |
$23K |
| 85027 |
|
2,278 |
1,860 |
$23K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
69 |
64 |
$18K |
| 73564 |
|
311 |
277 |
$17K |
| 87040 |
|
882 |
754 |
$17K |
| 84703 |
|
1,333 |
1,161 |
$15K |
| 73030 |
|
397 |
339 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
900 |
651 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,531 |
1,222 |
$13K |
| 83690 |
|
906 |
801 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,805 |
1,354 |
$12K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,003 |
196 |
$12K |
| 87186 |
|
1,707 |
1,338 |
$12K |
| 85007 |
|
2,276 |
1,856 |
$12K |
| 87077 |
|
1,319 |
1,026 |
$11K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
434 |
313 |
$9K |
| 83735 |
|
1,003 |
771 |
$8K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
679 |
396 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
149 |
129 |
$8K |
| 85730 |
|
815 |
703 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
224 |
183 |
$7K |
| 73630 |
|
260 |
213 |
$7K |
| 73110 |
|
269 |
204 |
$7K |
| 85610 |
|
1,393 |
1,094 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
357 |
307 |
$7K |
| 73130 |
|
188 |
163 |
$7K |
| 87420 |
|
528 |
472 |
$6K |
| 80050 |
General health panel |
140 |
134 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
981 |
843 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
152 |
113 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,045 |
909 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
471 |
412 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
93 |
84 |
$4K |
| 97161 |
|
83 |
80 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
604 |
501 |
$4K |
| 87070 |
|
327 |
274 |
$4K |
| 73610 |
|
188 |
151 |
$4K |
| 87140 |
|
425 |
340 |
$4K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
46 |
41 |
$4K |
| 71020 |
|
162 |
140 |
$3K |
| 80306 |
|
119 |
108 |
$3K |
| 71250 |
|
13 |
12 |
$3K |
| 80320 |
|
147 |
126 |
$2K |
| 80061 |
Lipid panel |
287 |
233 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
87 |
70 |
$2K |
| 82607 |
|
86 |
82 |
$1K |
| 82150 |
|
88 |
82 |
$921.10 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
151 |
134 |
$697.14 |
| 73562 |
|
14 |
12 |
$655.18 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
12 |
$508.98 |
| 85379 |
|
37 |
25 |
$460.67 |
| 83090 |
|
26 |
26 |
$313.17 |
| 82728 |
|
27 |
26 |
$259.12 |
| 80329 |
|
14 |
12 |
$236.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
476 |
378 |
$229.20 |
| 82565 |
|
15 |
12 |
$189.93 |
| 82746 |
|
12 |
12 |
$97.81 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
12 |
$95.59 |
| 83540 |
|
15 |
15 |
$95.43 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
104 |
81 |
$42.44 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
48 |
40 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
63 |
61 |
$0.00 |